Nature Chemical Biology

The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections. Read More

By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer. Read More

Vanderbilt University researchers and their Belgian colleagues have discovered the mechanism behind a multidrug transporter. Their findings, posted this week by Nature Chemical Biology, could lead to new treatments for multidrug resistant bacterial infections. Read More